Skip to main content

Table 6 Multiple linear regression analysis results of the associated factors of the total hospitalization expenses

From: How the National Health Insurance Coverage policy changed the use of lenvatinib for adult patients with advanced hepatocellular carcinoma: a retrospective cohort analysis with real world big data

Patient characteristics

Standardized coefficients

(Beta)

t

P

VIF

Gender

Male

-0.025

-2.690

0.007

1.02

Female

Ref

   

Age

≥ 18, < 35

-0.005

-0.480

0.630

1.46

≥ 35, < 50

-0.007

-0.370

0.714

4.27

≥ 50, < 65

-0.036

-1.440

0.151

7.64

≥ 65, < 80

0.017

0.700

0.482

6.93

≥ 80

Ref

   

Hospital level

The tertiary and above hospital

0.105

11.420

<0.001

1.01

Below the tertiary level

Ref

   

Type of insurance system

UEBMI

-0.016

-1.420

0.156

1.52

URRBMI

-0.009

-0.720

0.471

1.68

Uninsured

Ref

   

Location of residence

Urban

0.020

1.690

0.091

1.69

Rural

Ref

   

Division of provinces and cities

Nanjing area

-0.055

-3.480

0.001

3.01

Other areas of Jiangsu Province except Nanjing area

0.014

1.050

0.292

2.09

Outside of Jiangsu Province

Ref

   

Lenvatinib

Unused

0.062

6.700

<0.001

1.03

Used

Ref

   

Implementation of the NHIC policy

Before

-0.040

-4.280

<0.001

1.05

After

Ref

  Â